New Rule Will Make It Harder for Americans to Import Cheaper Prescription Drugs
A new regulation set to take effect on October 22 will make it more difficult for individuals in the U.S. to import prescription medications from other countries, such as Canada. Millions of Americans currently rely on mail-order pharmacies abroad to access cheaper alternatives to costly domestic prescriptions. The rule is expected to disrupt a common cost-saving strategy used by patients who cannot afford high drug prices within the United States. While it may reduce personal imports, critics argue that this could lead some individuals to seek unregulated or counterfeit medications instead if they remain unable to afford U.S.-priced drugs. This change reflects broader efforts in the U.S. to regulate pharmaceutical supply chains and ensure medication safety, but its impact on affordability for patients remains a concern.
Topics: healthcare policy international trade pharmaceuticals